MicrobiotiX Receives IND Approval for Novel Bacteriophage Drug MP101
Korea’s First Bacteriophage IND Approved by the Ministry of Food and Drug Safety – Phase 1 Trial to Begin in...
Antimicrobial
Data presented at ACR Convergence 2025 highlight Sobi’s commitment to advancing care across rare and underserved inflammatory conditions
NASP data highlight reduction in disease burden among people living with uncontrolled gout Gamifant (emapalumab) data showed response rates in...
BioLab Holdings, Inc. Announces Investment in Cold Atmospheric Plasma Technology
Partnership Will Advance Portable Antimicrobial Solutions for Wound Care and Dermatology PHOENIX, Oct. 24, 2025 /PRNewswire/ -- BioLab Holdings, Inc.,...
CorMedix Inc. Receives Innovative Technology Designation From Vizient for DefenCath
BERKELEY HEIGHTS, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...
FendX Files Provisional Patent for Novel Antimicrobial Nanoparticle Liquid Coating
Vancouver, British Columbia--(Newsfile Corp. - October 22, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company"...
VTT identifies new plant-based anti-inflammatory and anti-ageing ingredients for sustainable cosmetics
ESPOO, Finland, Oct. 15, 2025 /PRNewswire/ -- In a landmark collaborative project, scientists at the VTT Technical Research Centre of...
Pictor’s Proteomics Platform Offers Promising Advancement for Detecting Mycoplasma bovis in Cattle
New research highlights the Pictor PictVet™ Mycoplasma bovis IgG Multiplex ELISA's enhanced analytical performance through multiplexing and its potential to...
Theriva™ Biologics Announces Upcoming Presentations at Medical Meetings
- VCN-01 expanded mPDAC data from VIRAGE Phase 2b trial to be presented at ESMO 2025 - - SYN-004 Interim...
Immuron Q1 FY26 YoY growth
Sales Highlights (unaudited): Global•Q1 sales AUD$2.0 million up 34% on prior comparative period (pcp) Australia•Q1 sales AUD$1.6 million up 52% on...
Novo Nordisk Foundation commits up to DKK 200 million to fund new platform to strengthen global defence against future pandemics
COPENHAGEN, Denmark, Oct. 13, 2025 /PRNewswire/ -- The AI-powered Global Pathogen Analysis Platform aims to strengthen the pandemic preparedness globally....
Genvor Restores Trading Status and Expands Global Collaborative Research Network
Woodland, CA, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Genvor, Inc. (OTCID: GNVR), a pioneer in AI-accelerated peptide technology for sustainable...
Reolite Secures Historic U.S. EPA Registration and Earns Recognition from MIT Lincoln Laboratory, Paving the Way for Entry into $2.7 Trillion Apparel and Plastics Markets
LOS ANGELES, Oct. 6, 2025 /PRNewswire/ -- Robin K. International Inc. (DBA Reolite, Chairman Billy Kang), headquartered in Los Angeles,...
Nutromics unveils world-first real-time in vivo multiplexing data at IATDMCT
MELBOURNE, Australia, Oct. 2, 2025 /PRNewswire/ -- Diagnostics company Nutromics has presented the world's first real-time, continuous data on two...
Sanara MedTech to Report Third Quarter 2025 Financial Results on November 12, 2025
FORT WORTH, TX, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical...
AUA Guidelines Recognize NGS in Recurrent UTI Care, Signaling Progress
NGS use is validated in 2025 American Urological Association guideline update, marking an important step towards more accurate and rapid...
CorMedix Announces Completion of Enrollment in Phase III ReSPECT Clinical Trial for REZZAYO
- Enrollment Completed in Ongoing Phase III ReSPECT Study in Prophylaxis of Fungal Infections in Adult Patients Undergoing Allogeneic Blood...
Basilea awarded BARDA contract for the development of novel oral phase 3-ready antibiotic ceftibuten-ledaborbactam
- Total non-dilutive funding of up to USD 159 million upon completion of predefined milestones, including near-term committed funding of...
Vanderbilt Report: Full Alliance Group helps Power Hypochlorous Acid’s Breakout from Hospitals to the Global Consumer Market
BRISTOL, Tenn., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Once relegated to the back rooms of hospitals, hypochlorous acid (HOCl) is...
Seres Therapeutics Announces Further Constructive Feedback from FDA on SER-155 Phase 2 Study Protocol and Implements Cost Reduction Actions to Extend Cash Runway
Following recent constructive FDA feedback, Seres anticipates finalizing SER-155 Phase 2 study protocol for the prevention of bloodstream infections in...
Viromed Medical AG initiates approval process for PulmoPlas(R) with the Federal Institute for Drugs and Medical Devices (BfArM)
RELLINGEN, DE / ACCESS Newswire / September 23, 2025 / Viromed Medical AG ("Viromed"; ISIN: DE000A3MQR65), a medical technology company...